Clinical Trial Update: Predicting the Response to Montelukast by Genetic Variation in Asthmatics [Phase 3]

View source ↗

Summary

Phase 3 trial investigating how genetic variation predicts response to montelukast in asthmatics has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Asthma | Phase 3 | Status: COMPLETED